We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$137M
Cap. Flow %
3.08%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,516
Reduced
1,175
Closed
233

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Healthcare 9.75%
3 Financials 7.52%
4 Communication Services 4.86%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1476
BeOne Medicines Ltd
ONC
$40.6B
$65.6K ﹤0.01%
241
+32
+15% +$7.48K
RWO icon
1477
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.29B
$65.6K ﹤0.01%
1,502
+10
+0.7% +$436
LFUS icon
1478
Littelfuse
LFUS
$11.6B
$65.5K ﹤0.01%
333
+171
+106% +$39.1K
CFR icon
1479
Cullen/Frost Bankers
CFR
$10.3B
$65.4K ﹤0.01%
522
+132
+34% +$17.7K
BWA icon
1480
BorgWarner
BWA
$14.1B
$65.2K ﹤0.01%
2,277
-450
-17% -$13.7K
JQUA icon
1481
JPMorgan US Quality Factor ETF
JQUA
$8.57B
$65.2K ﹤0.01%
1,154
-48
-4% -$2.8K
PAC icon
1482
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$64.9K ﹤0.01%
350
+59
+20% +$11.2K
BROS icon
1483
Dutch Bros
BROS
$8.96B
$64.7K ﹤0.01%
1,048
+29
+3% +$1.91K
WST icon
1484
West Pharmaceutical
WST
$24.8B
$64.7K ﹤0.01%
289
-192
-40% -$52.9K
ACI icon
1485
Albertsons Companies
ACI
$5.89B
$64.6K ﹤0.01%
2,936
+201
+7% +$4.15K
PBH icon
1486
Prestige Consumer Healthcare
PBH
$2.51B
$64.5K ﹤0.01%
750
ASB icon
1487
Associated Banc-Corp
ASB
$5.92B
$64.4K ﹤0.01%
2,861
+227
+9% +$5.45K
UVSP icon
1488
Univest Financial
UVSP
$1.16B
$64.4K ﹤0.01%
2,271
-27
-1% -$799
ZBRA icon
1489
Zebra Technologies
ZBRA
$17.9B
$64.1K ﹤0.01%
227
-53
-19% -$18.1K
DHIL
1490
DELISTED
Diamond Hill
DHIL
$64.1K ﹤0.01%
449
-35
-7% -$5.17K
FDMT icon
1491
4D Molecular Therapeutics
FDMT
$582M
$63.8K ﹤0.01%
19,745
NVDL icon
1492
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.63B
$63.6K ﹤0.01%
5,100
+4,035
+379% +$74.1K
SRPT icon
1493
Sarepta Therapeutics
SRPT
$1.81B
$63.6K ﹤0.01%
993
+170
+21% +$17.9K
BSJP
1494
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
$63.5K ﹤0.01%
2,757
AMKR icon
1495
Amkor Technology
AMKR
$13.1B
$63.4K ﹤0.01%
3,509
-535
-13% -$12.1K
IONQ icon
1496
IonQ
IONQ
$15.9B
$63.2K ﹤0.01%
2,865
-232
-7% -$7.52K
HASI icon
1497
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.18B
$63.2K ﹤0.01%
2,159
+2,094
+3,222% +$59.3K
MNDY icon
1498
monday.com
MNDY
$3.75B
$63K ﹤0.01%
259
-72
-22% -$19K
WERN icon
1499
Werner Enterprises
WERN
$2.2B
$62.9K ﹤0.01%
2,147
-1,417
-40% -$47.6K
RLI icon
1500
RLI Corp
RLI
$5.83B
$62.6K ﹤0.01%
779
-561
-42% -$42.7K

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $137M of net new capital in Q1 2025, opening 225 new positions and adding to 1,516 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.